(Q28145823)

1

0 references

K Taylor

2

0 references

J Otto

3

0 references

S Aho

4

0 references

J Uitto

5

0 references

J M Whitelock

6

0 references

R V Iozzo

Journal of Biological Chemistry

7

0 references

language of work or name

English

0 references

publication date

10 March 2000

0 references

published in

0 references

volume

275

0 references

issue

10

0 references

page(s)

7095-100

0 references

cites work

Diversity does make a difference: fibroblast growth factor-heparin interactions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Matrix proteoglycans: from molecular design to cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

The core protein of the chondroitin sulfate proteoglycan phosphacan is a high-affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Two-hybrid analysis reveals multiple direct interactions for thrombospondin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Proteoglycans of basement membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Recombinant domain III of perlecan promotes cell attachment through its RGDS sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

A novel genetic system to detect protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Structural and cell-adhesive properties of three recombinant fragments derived from perlecan domain III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095

Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.10.7095